Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Changtai Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and manufacturing of high-end generic and innovative drugs. The company focuses on therapeutic areas such as respiratory medicine, anesthesia, and cardiovascular health. It operates advanced manufacturing facilities and has a pipeline that includes complex formulations like inhalation aerosols and injectable peptides. Changtai is known for its commitment to quality and international standards, aiming to provide affordable and effective treatments for chronic and acute conditions. The company is headquartered in the China Medical City in Taizhou and maintains a strong focus on high-barrier drug delivery technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangsu Changtai Pharmaceutical.